Taro Pharmaceutical Industries Ltd. logo

Taro Pharmaceutical Industries Ltd.

Sector: 
Healthcare
   

Industry: 
Drug Manufacturers - Specialty & Generic

35.55
 
USD
  
0.65
  
(1.86%)
Optionable: Yes  Market Cap: 1,335 M  90-day average vol: 32,673

Previous close: 34.9  Open: 34.92  Bid:   Ask:
52 week range    
33.36   
   72.97
Peers   
MRK / 
PFE / 
JNJ / 
TEVA / 
GSK / 
Last updated: Monday 8th August 2022
39
MarketXLS Rank marketxls
60
Value marketxls
23
Technical marketxls
36
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

GSK

JNJ

0.0247450 B22.1171.06

MRK

0.0356207 B28.877.58

NVS

PFE

0.0302298 B15.153.21

TEVA

Chart
News
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 6.834


Financials

TARO Income Statement

Annual

Mar-13Mar-14Mar-15Mar-16Mar-17Mar-18Mar-19Mar-20Mar-21Mar-22
Total revenues671 M759 M863 M951 M879 M662 M670 M645 M549 M561 M
Cost of sales158 M163 M171 M157 M193 M182 M206 M224 M229 M229 M
Gross operating profit495 M580 M677 M779 M671 M464 M446 M400 M297 M293 M
Selling Gen & administrative expense120 M94 M83 M93 M86 M90 M86 M93 M91 M114 M
Research & development expense47 M55 M66 M71 M71 M70 M63 M60 M60 M55 M
Operating income362 M433 M523 M615 M515 M305 M296 M247 M145 M125 M
floaterest income0000000000
floaterest expense0000000000
Other income net-28 M6 M49 M9 M31 M-32 M27 M18 M-556 M-55 M
Pre-tax Income (EBT)336 M444 M582 M637 M561 M292 M357 M298 M-391 M78 M
Income taxes68 M83 M96 M95 M104 M82 M75 M53 M10 M20 M
Net income from total operations267 M361 M485 M541 M457 M210 M282 M245 M-401 M58 M
Minority floaterest0000000000
Total net income266 M360 M484 M541 M456 M211 M282 M244 M-387 M58 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common268 M361 M486 M542 M457 M210 M282 M245 M-401 M58 M
Depreciation18 M17 M16 M15 M15 M16 M19 M21 M24 M39 M
Amortization0000000000
Operating income before depreciation (EBITDA)356 M462 M598 M652 M576 M309 M376 M320 M-366 M151 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total5.968.1411.3112.6211.055.267.236.35-10.121.55
Diluted EPS total5.958.1411.3112.6211.055.267.236.35-10.121.55
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!